The University of Saskatchewan's Vaccine and Infectious Disease Organization (VIDO) is a key partner in a $2-million Canada-India initiative to improve food safety through the application of biotechnology in developing an innovative device for rapidly diagnosing disease in cattle.
University of Saskatchewan history professor James Miller has been awarded $1.4 million from the federal Canada Research Chair (CRC) program to advance his study of how churches and the federal government have attempted to make amends with residential school victims.
University of Saskatchewan microbiologist Wei Xiao has found a way to trigger a protein combination called 9-1-1 that sends an SOS signal for cells to fight cancer-causing agents such as industrial toxins, ultraviolet radiation, and X-rays.
University of Saskatchewan health scientists are working on a cure for asthma and a needle-free vaccine for a childhood respiratory virus thanks to major Canadian Institutes of Health Research (CIHR) grants announced today.
Scientific leaders from three of Canada's foremost public health vaccine research agencies will gather on the University of Saskatchewan campus tomorrow to officially launch the $25.5-million Pan-Provincial Vaccine Enterprise (PREVENT), a new national vaccine commercialization consortium.
As people around the world prepare to celebrate Earth Day on Tuesday, April 22, researchers at the University of Saskatchewan (U of S) are doing their part by developing smart, practical, green solutions to better the environment.
University of Saskatchewan Canada Research Chair John Tse and colleagues in Germany have identified a new family of superconductors"”research that could eventually lead to the design of better superconducting materials for a wide variety of industrial uses.
A team of Alberta and Saskatchewan health scientists has been awarded a $2.25-million team grant from the Canadian Institutes of Health Research (CIHR) to study how best to heal and regrow nerves damaged by injury or disease.
Saskatoon, SK. The University of Saskatchewan will lead a $25.5-million national Centre of Excellence for Commercialization and Research aimed at fast-tracking vaccine development for diseases of major public health concern such as pandemic influenza, whooping cough, chlamydia, "mad cow" disease, and severe diarrheal diseases.
A University of Saskatchewan team of scientists has isolated a gene that has never before been identified in helping plants to resist stress. The study"”published this month in the top-ranked plant journal The Plant Cell"”could pave the way for development of agricultural and forestry crops that are more tolerant to environmental stresses such as ultra-violet light and other types of radiation.
Shedding light on the link between stress and disease, scientists at the University of Saskatchewan's Vaccine and Infectious Disease Organization (VIDO) have uncovered for the first time signs of stress in proteins and other compounds found in blood that can help predict disease susceptibility.
Today representatives of all three levels of government and the Canada Foundation for Innovation turned the sod to launch construction of the International Vaccine Centre (InterVac) at the University of Saskatchewan, a $110.4-million project that will significantly enhance Canada's capacity to fight infectious disease in both animals and humans.
A University of Saskatchewan professor lauded for his groundbreaking work in reproductive biology and leadership in medical imaging will receive this spring's Distinguished Researcher Award at the Spring Convocation ceremony on June 5 at TCU Place in Saskatoon.
A research team from the University of Saskatchewan and Saskatoon Health Region is examining intimate partner violence in Saskatchewan from all sides in an effort to find community-based solutions to this very private problem.
Andrew Potter, an internationally recognized authority on vaccine development, will become the new Director of the University of Saskatchewan's Vaccine and Infectious Disease Organization (VIDO) starting July 1, Vice-President Research Steven Franklin announced today.
University of Saskatchewan health researcher John Gordon is working to develop a new anti-inflammatory drug that could ease the suffering of people with arthritis, inflammatory bowel disease, and cystic fibrosis, as well as reduce damage caused by heart attacks and strokes.
Three researchers from the University of Saskatchewan and the Saskatoon Health Region are studying immunization rates among Aboriginal children, healthy body weight and image among rural Aboriginal women, and the health and well being of on-reserve Aboriginal youth.
Four University of Saskatchewan research teams, whose innovations range from more profitable biodiesel and a better tomato to a novel gene for fast-maturing crops and a new anti-inflammatory drug, have been nominated for the Innovation Place"“Industry Liaison Office Award of Innovation.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right